Glycolysis in the Progression of Pancreatic Cancer

Overview

Journal Am J Cancer Res

Specialty Oncology

Date 2022 Mar 9

PMID 35261808

Authors

Xinyao Chang

Xingchen Liu

Haoze Wang

Xuan Yang

Yan Gu

Affiliations

Soon will be listed here.

Abstract

Metabolic reprogramming, as a key hallmark of cancers, leads to the malignant behavior of pancreatic cancer, which is closely related to tumor development and progression, as well as the supportive tumor microenvironments. Although cells produce adenosine triphosphate (ATP) from glucose by glycolysis when lacking oxygen, pancreatic cancer cells elicit metabolic conversion from oxide phosphorylation to glycolysis, which is well-known as "Warburg effect". Glycolysis is critical for cancer cells to maintain their robust biosynthesis and energy requirement, and it could promote tumor initiation, invasion, angiogenesis, and metastasis to distant organs. Multiple pathways are involved in the alternation of glycolysis for pancreatic cancer cells, including UHRF1/SIRT4 axis, PRMT5/FBW7/cMyc axis, JWA/AMPK/FOXO3a/FAK axis, KRAS/TP53/TIGAR axis, etc. These signaling pathways play an important role in glycolysis and are potential targets for the treatment of pancreatic cancer. Mutations in glycolytic enzymes (such as LDH, PKM2, and PGK1) also contribute to the early diagnosis and monitoring of pancreatic cancer. In this review, we summarized the recent advances on the mechanisms for glycolysis in pancreatic cancer and the function of glycolysis in the progression of pancreatic cancer, which suggested new targets for cancer diagnosis and treatment.

Citing Articles

Metabolic reprogramming in cancer and senescence.

Zhang Y, Tang J, Jiang C, Yi H, Guang S, Yin G MedComm (2020). 2025; 6(3):e70055.

PMID: 40046406 PMC: 11879902. DOI: 10.1002/mco2.70055.

The emerging role of glycolysis and immune evasion in ovarian cancer.

Jin B, Miao Z, Pan J, Zhang Z, Yang Y, Zhou Y Cancer Cell Int. 2025; 25(1):78.

PMID: 40045411 PMC: 11881340. DOI: 10.1186/s12935-025-03698-x.

Nanotechnology-driven EGCG: bridging antioxidant and therapeutic roles in metabolic and cancer pathways.

Esmaeili Z, Shavali Gilani P, Khosravani M, Motamedi M, Maleknejad S, Adabi M Nanomedicine (Lond). 2025; 20(6):621-636.

PMID: 39924937 PMC: 11881875. DOI: 10.1080/17435889.2025.2462521.

Targeting KRAS: from metabolic regulation to cancer treatment.

Shi Y, Zheng H, Wang T, Zhou S, Zhao S, Li M Mol Cancer. 2025; 24(1):9.

PMID: 39799325 PMC: 11724471. DOI: 10.1186/s12943-024-02216-3.

Potent Biological Activity of Fluorinated Derivatives of 2-Deoxy-d-Glucose in a Glioblastoma Model.

Soltyka-Krajewska M, Ziemniak M, Zawadzka-Kazimierczuk A, Skrzypczyk P, Siwiak-Niedbalska E, Jaskiewicz A Biomedicines. 2024; 12(10).

PMID: 39457553 PMC: 11504489. DOI: 10.3390/biomedicines12102240.

References

Wang S, Wu X, Chen Y, Zhang J, Ding J, Zhou Y . Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer. Clin Cancer Res. 2012; 18(10):2987-96. DOI: 10.1158/1078-0432.CCR-11-2863. View

Ou X, Lv W . Metabolic changes and interaction of tumor cell, myeloid-derived suppressor cell and T cell in hypoxic microenvironment. Future Oncol. 2020; 16(8):383-393. DOI: 10.2217/fon-2019-0692. View

Liu W, Zhang B, Hu Q, Qin Y, Xu W, Shi S . A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism. Int J Oncol. 2017; 50(5):1792-1800. DOI: 10.3892/ijo.2017.3938. View

Mohammad G, Olde Damink S, Malago M, Dhar D, Pereira S . Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome. PLoS One. 2016; 11(3):e0151635. PMC: 4798246. DOI: 10.1371/journal.pone.0151635. View

Rothman D, Shulman R . Two transition states of the glycogen shunt and two steady states of gene expression support metabolic flexibility and the Warburg effect in cancer. Neoplasia. 2021; 23(9):879-886. PMC: 8322124. DOI: 10.1016/j.neo.2021.06.004. View

Xian Z, Liu J, Chen Q, Chen H, Ye C, Xue J . Inhibition of LDHA suppresses tumor progression in prostate cancer. Tumour Biol. 2015; 36(10):8093-100. PMC: 4605959. DOI: 10.1007/s13277-015-3540-x. View

Jia Y, Li H, Wang J, Wang Y, Zhang P, Ma N . Phosphorylation of 14-3-3ζ links YAP transcriptional activation to hypoxic glycolysis for tumorigenesis. Oncogenesis. 2019; 8(5):31. PMC: 6510816. DOI: 10.1038/s41389-019-0143-1. View

Gaustad J, Simonsen T, Andersen L, Rofstad E . Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts. J Transl Med. 2017; 15(1):241. PMC: 5706333. DOI: 10.1186/s12967-017-1347-9. View

Koong A, Mehta V, Le Q, Fisher G, Terris D, Brown J . Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys. 2000; 48(4):919-22. DOI: 10.1016/s0360-3016(00)00803-8. View

10.

Tang S, Ho M, Cho H, Lin Y, Sun G, Chi K . Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo. Int J Cancer. 2008; 123(12):2840-8. DOI: 10.1002/ijc.23888. View

11.

Zhao D, Zou S, Liu Y, Zhou X, Mo Y, Wang P . Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Cancer Cell. 2013; 23(4):464-76. PMC: 3885615. DOI: 10.1016/j.ccr.2013.02.005. View

12.

Geng J, Yuan X, Wei M, Wu J, Qin Z . The diverse role of TIGAR in cellular homeostasis and cancer. Free Radic Res. 2018; 52(11-12):1240-1249. DOI: 10.1080/10715762.2018.1489133. View

13.

Talesa V, Ferri I, Bellezza G, Love H, Sidoni A, Antognelli C . Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERα. Prostate. 2016; 77(2):196-210. DOI: 10.1002/pros.23261. View

14.

Kamisawa T, Wood L, Itoi T, Takaori K . Pancreatic cancer. Lancet. 2016; 388(10039):73-85. DOI: 10.1016/S0140-6736(16)00141-0. View

15.

Zorde Khvalevsky E, Gabai R, Rachmut I, Horwitz E, Brunschwig Z, Orbach A . Mutant KRAS is a druggable target for pancreatic cancer. Proc Natl Acad Sci U S A. 2013; 110(51):20723-8. PMC: 3870687. DOI: 10.1073/pnas.1314307110. View

16.

Zhang Z, Deng X, Liu Y, Liu Y, Sun L, Chen F . PKM2, function and expression and regulation. Cell Biosci. 2019; 9:52. PMC: 6595688. DOI: 10.1186/s13578-019-0317-8. View

17.

Morrison A, Byrne K, Vonderheide R . Immunotherapy and Prevention of Pancreatic Cancer. Trends Cancer. 2018; 4(6):418-428. PMC: 6028935. DOI: 10.1016/j.trecan.2018.04.001. View

18.

Lunt S, Vander Heiden M . Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011; 27:441-64. DOI: 10.1146/annurev-cellbio-092910-154237. View

19.

Wang X, Yin G, Zhang Z, Rong Z, Wang Z, Du D . TWIST1 transcriptionally regulates glycolytic genes to promote the Warburg metabolism in pancreatic cancer. Exp Cell Res. 2019; 386(1):111713. DOI: 10.1016/j.yexcr.2019.111713. View

20.

Chen X, Tao Y, He M, Deng M, Guo R, Sheng Q . Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cancer progression and metastasis. Theranostics. 2021; 11(18):8692-8705. PMC: 8419034. DOI: 10.7150/thno.60437. View